Astrazeneca Share News (AZN)

Hillary Clinton Outlines Plans To Stop Drug Industry "Price Gouging"

LONDON MARKET CLOSE: Commodities And Pharma Push FTSE 100 Below 6,000

LONDON MARKET MIDDAY: Miners, Drug Makers And VW Drive FTSE 100 Lower

AstraZeneca taps crowd sourcing to find cancer drug cocktails

LONDON, Sept 22 (Reuters) - Drugmaker AstraZeneca is harnessing the wisdom of crowds to help mix tomorrow's cancer drug cocktails. The company said on Tuesday its decision to release preclinical data from more than 50 of its medicines was unprecedented in scale and would help accelerate the

LONDON MARKET OPEN: Drug Stocks Hit By Clinton Price-Gouging Tweet

LONDON BRIEFING: Miners And Drug Stocks Hit By Downgrades And A Tweet

Dunedin Income Growth Underperforms FTSE All Share In Half Year

Roche shows its intent with Switzerland's tallest skyscraper

By John Miller BASEL, Sept 18 (Reuters) - Visible from neighbouring France and Germany, a new 41-storey skyscraper that drugs company Roche opened near the river Rhine on Friday reaches 178 meters into the sky, easily the tallest building in Switzerland. The 550-million Swiss franc (

UPDATE 2-Lilly diabetes drug slashes deaths in patients with heart risk

(Adds analyst estimates on Jardiance sales and Lilly earnings, details on study, medical comment; updates share price) By Ransdell Pierson Sept 17 (Reuters) - Eli Lilly and Co's new Jardiance pill slashed deaths by 32 percent in patients with type 2 diabetes at risk of heart attack an

BUZZ-Lilly shares add to gains after diabetes drug finding

(Updates price, adds stock symbol) ** Shares of Eli Lilly and Co up 6 pct at $89.74, giving the biggest boost to the S&P 500, following positive drug news ** Its new Jardiance pill slashed deaths by 32 pct in a study of 7,000 patients with type 2 diabetes at risk of heart attack and s

Synairgen Swings To Loss As AstraZeneca Revenue Bump Doesn't Repeat

Broker tips: Henderson Group, AstraZeneca, IAG

(ShareCast News) - Exane BNP Paribas took a look at UK asset managers, noting that their shares have sold off sharply, making for an enticing entry point. "Equity market volatility is a risk to inflows, but historically the impact has been temporary and flows into other asset classes do not suffer a

LONDON MARKET CLOSE: UK Stocks Down As Analysts Differ On Fed Decision

LONDON MARKET MIDDAY: NY Seen Up As Fed Decision Week Gets Underway

Deutsche Bank ups AstraZeneca to 'buy'; sees return to strong growth

(ShareCast News) - Deutsche Bank upgraded AstraZeneca to 'buy' from 'hold' and raised its price target to 5,700p from 4,850p. The bank said it's increasingly confident in AstraZeneca's ability to deliver a return to strong growth from a base in 2017. "We have increased our outer year sales and earn